Kathy L Hibbs
CIK 1267487 · Chief Administrative Officer · last filed 2026-09-10
Kathy L Hibbs is a Chief Administrative Officer who has filed 82 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $50.8K of SOPH on Sep 10, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $781.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ME price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2 TOWER PLACE, STE 2000
SOUTH SAN FRANCISCO, CA 94080
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOPH | Director | 96,992 | $6.49 | $629.5K | -$140.1K | 4 | 2026-09-10 |
| LAB | Director | 236,836 | $0.64 | $152.4K | $0 | 4 | 2026-06-23 |
| Chrome Holding Co. (ME) Delisted | Chief Administrative Officer | 60,852 | $0.61 | $36.9K | -$924.2K | 37 | 2024-05-21 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | — | $0.09 | — | $0 | 1 | 2023-06-12 |
| GENOMIC HEALTH INC (GHDX) Delisted | SVP & General Counsel | 17,841 | — | — | -$235.7K | 10 | 2014-02-19 |
| Monogram Biosciences, Inc. (MGRM) Delisted | Sr. VP, General Counsel | — | $6.00 | — | $0 | 4 | 2009-01-22 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-10 | SOPH | Sell (S) | −6,250 | -$50.8K | EDGAR |
| 2026-08-26 | SOPH | Sell (S) | −6,250 | -$54.2K | EDGAR |
| 2026-08-25 | SOPH | Notice (144) | −18,750 | -$158.4K | EDGAR |
| 2026-06-23 | LAB | Grant (A) | +99,116 | $0 | EDGAR |
| 2026-06-22 | SOPH | Grant (A) | +19,724 | $107.7K | EDGAR |
| 2026-05-13 | SOPH | Sell (S) | −7,508 | -$35.0K | EDGAR |
| 2026-03-10 | SOPH | Notice (144) | −15,508 | -$69.2K | EDGAR |
| 2025-11-03 | SOPH | Notice (144) | −10,000 | -$50.0K | EDGAR |
| 2025-06-30 | SOPH | Notice (144) | −10,000 | -$30.9K | EDGAR |
| 2025-06-24 | LAB | Grant (A) | +94,592 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.